iNtRON Biotechnology, Inc.
KOE: 048530.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Seong-Jun Yoon
- Employees
- 76
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2011
- Market cap
- ₩104.7B
- Website
- https://www.intron.co.kr
Loading 048530…
Loading profile data…Frequently asked questions about 048530
What does iNtRON Biotechnology, Inc. (048530.KQ) do?
iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
Where does 048530.KQ trade?
iNtRON Biotechnology, Inc. (048530.KQ) trades on the KOSDAQ.
What sector is 048530.KQ in?
iNtRON Biotechnology, Inc. (048530.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of iNtRON Biotechnology, Inc.?
Seong-Jun Yoon is the chief executive officer of iNtRON Biotechnology, Inc. (048530.KQ).
Where is iNtRON Biotechnology, Inc. headquartered?
iNtRON Biotechnology, Inc. is headquartered in South Korea.
Does 048530.KQ pay a dividend?
Yes — iNtRON Biotechnology, Inc. (048530.KQ) paid a trailing twelve-month dividend of KRW 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 048530.KQ go public?
iNtRON Biotechnology, Inc. (048530.KQ) completed its initial public offering in 2011.